Evaluation of the immunomodulatory activity of probiotics mixture and sulfasalazine against acetic acid-induced colitis in a murine model
Molecular Biology Reports · 2024
DOI: 10.1007/s11033-024-10008-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Mona Moshiri und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. Hauptthemen laut MEDLINE: Probiotics, Sulfasalazine, Colitis, Disease Models, Animal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Currently, the use of probiotics to treat inflammatory bowel diseases (IBD) is widely accepted because of their gut microbiota modulation capabilities and anti-inflammatory potential. OBJECTIVE: The aim of this study is to examine the immunomodulatory outcomes of probiotics and sulfasalazine in the acetic acid-induced colitis murine model. METHODS: The animals were randomly assigned to one of the seven groups. Following the induction of colitis, Lactobacillus acidophilus LA-5, Bifidobacterium animalis subsp. lactis BB-12, and sulfasalazine (SASP) were orally administered for 10 days. Subsequently, the in vitro anti-inflammatory effect on TNF-α and IL-10 in the supernatants of cultured spleen cells was assessed via ELISAs. Relative mRNA expression of ZO-1, MLCK, iNOS, TNFR2, ROR-γt, GATA-3, T-bet, and Foxp3 was determined using quantitative reverse‑transcription polymerase chain reaction (qRT‑PCR). RESULTS: The SASP plus probiotic mixture was more effective in alleviating colitis symptoms, and reducing disease activity scores, and mucosal inflammation. qRT-PCR analysis revealed a significant reduction in T-bet and RORγt levels, while Foxp3 and GATA-3 levels increased in the colons of colitis mice. In addition, the selected strains substantially inhibited the release of inflammatory markers. Administration of LA-5 + BB-12 + SASP resulted in considerably higher inhibition of NO production and cell proliferation than in the other groups (p < 0.001). Treatment with LA-5 + BB-12 + SASP also reduced TNF-α-mediated apoptosis in intestinal epithelial cells (IECs). CONCLUSIONS: Survey results highlight that the combination regimen could be a promising strategy for IBD therapy, warranting further study of its clinical application and long-term benefits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
- Immunogenetics Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
- Department of Microbiology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
- Department of Pathology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
- Department of Anatomy, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
- Department of Immunology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. abedianlab@yahoo.co.uk.
Zitieren
APA
Moshiri, M., Faghih, M., Gholami, M., Ghasemi, M., Jafari, N., Mirzaei, M., & Abediankenari, S. (2024). Evaluation of the immunomodulatory activity of probiotics mixture and sulfasalazine against acetic acid-induced colitis in a murine model. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-10008-7
Vancouver
Moshiri M, Faghih M, Gholami M, Ghasemi M, Jafari N, Mirzaei M, et al. Evaluation of the immunomodulatory activity of probiotics mixture and sulfasalazine against acetic acid-induced colitis in a murine model. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-10008-7
BibTeX
@article{Moshiri2024,
author = {Moshiri, Mona and Faghih, Manizhe and Gholami, Mehrdad and Ghasemi, Maryam and Jafari, Narjes and Mirzaei, Mansooreh and Abediankenari, Saeid},
title = {Evaluation of the immunomodulatory activity of probiotics mixture and sulfasalazine against acetic acid-induced colitis in a murine model},
journal = {Molecular Biology Reports},
year = {2024},
doi = {10.1007/s11033-024-10008-7}
}
EUVIMED